How we helped a biotech innovator overcome clinical trial obstacles: A journey to success!

We understand that every clinical trial is a race against time. Our expertise in patient recruitment, regulatory approvals, and site management has helped biotech and pharmaceutical companies successfully bring life-saving treatments to market faster.

Here’s how we partnered with a biotechnology firm to turn around their Phase II oncology trial, helping them accelerate patient enrollment, secure faster regulatory approvals, and improve trial efficiency—all backed by real numbers.

Challenges

Challenge 1

A mid-sized biotech firm was conducting a Phase II clinical trial for an innovative oncology drug aimed at treating advanced-stage lung cancer. However, their study was falling behind schedule, putting their regulatory submission and funding at risk.

Challenge 2

Patient Recruitment Was Lagging – Only 20% of the enrollment target was met within the first 6 months. Without a strong recruitment strategy, the trial was at risk of missing its critical milestones, delaying the drug’s potential launch.

Challenge 3

Regulatory Approvals Were Delayed – Multi-country submissions took 45% longer than expected. The complexity of global regulatory requirements created multiple bottlenecks, requiring constant re-submissions and clarifications.

Challenge 4

Site Compliance Issues – Over 12% protocol deviations and 3 critical compliance violations were recorded, increasing risk. These errors not only slowed down trial progress but also posed a significant risk to the integrity of the study results.

Solution: Patient Recruitment: 50% Faster Enrollment

One of the biggest challenges was recruiting 200 eligible patients within 7 months. Our team implemented a multi-channel patient recruitment strategy, ensuring faster and more effective engagement.
Data-Driven Records – We analyzed over 1000 patients records using data driving records analytics to identify high-potential candidates who matched the trial’s eligibility criteria. This reduced screening failures and improved recruitment efficiency.
Digital Recruitment Campaigns – We launched targeted digital campaigns on social media, healthcare platforms, and patient communities, increasing engagement by 25% compared to traditional recruitment methods. Personalized messaging helped attract motivated participants.
Site Expansion – By increasing the number of trial sites from 18 to 26, we ensured that more patients had access to the study. This strategic move resulted in a 30% increase in site-level recruitment rates, significantly improving overall enrollment speed.

Outcomes:

Recruitment increased by 50%, allowing the client to meet their target 4 months ahead of schedule.
Patient retention rate improved to 92%, reducing dropout rates and ensuring trial continuity.
Average enrollment time per site reduced from 3.2 months to 1.9 months, keeping the trial on track.

Solution: Regulatory Approval: 35% Faster Multi-Country Approvals

The Biotech firm was struggling with complex regulatory submissions across multiple regions. Our team streamlined the process to avoid delays.
Regulatory Submission Optimization – We ensured that every submission was error-free and fully compliant with the latest FDA, EMA, and DCGI guidelines. This eliminated the need for extensive rework and resubmissions.
AI-Driven Document Review – By integrating AI-powered tools, we reduced submission errors by 28%, ensuring quicker acceptance. These tools helped identify inconsistencies in regulatory documents before submission.
Direct Collaboration with Regulators – Our regulatory affairs specialists maintained continuous communication with global regulatory bodies, addressing queries in real time. This proactive approach cut down response times by 40%.

Outcomes:

Regulatory approval was secured 35% faster, reducing delays by 5 months and keeping the trial on track.
Error rate in submissions dropped from 14% to just 3%, ensuring smooth acceptance.
Back-and-forth communication with regulators reduced by 40%, saving time and effort.

Solution: Site Management: 60% Reduction in Compliance Issues

Poor site management and compliance issues were threatening trial integrity. We took a hands-on approach to resolve these challenges.
Real-Time Monitoring System – We implemented a centralized monitoring platform that allowed real-time tracking of all site activities. This led to a 60% reduction in protocol deviations by flagging issues before they escalated.
On-Site Staff Training – Our team conducted over 200 hours of GCP (Good Clinical Practice) training for site staff, improving adherence to trial protocols and reducing non-compliance.
Automated Data Capture – We introduced electronic data capture (EDC) tools, reducing manual errors and improving data accuracy by 42%. This ensured clean, reliable, and high-quality trial data.

Outcomes:

Protocol deviations reduced from 12% to just 4.5%, minimizing risks and improving trial credibility.
Query resolution time at sites improved by 55%, ensuring faster issue resolution and trial continuity.
Data quality scores improved by 33%, making the trial data more robust and reliable.

The Final Results: A Trial Turned Around

Patient enrollment completed 2 months ahead of schedule, preventing costly delays.
Regulatory approvals secured 5 months faster, accelerating market entry and reducing risk.
Site compliance issues reduced by 60%, ensuring high-quality, reliable trial data.
Total trial costs reduced by an estimated $5.2 million, increasing ROI for the sponsor.

A Step Closer to Saving Lives

With our expert support, the client successfully completed their Phase II trial on time, paving the way for regulatory submission and future commercialization.
Their confidence in our expertise, strategic approach, and commitment to excellence has led to a long-term partnership.

View More Case Studies

How we helped a biotech innovator overcome clinical trial obstacles: A journey to success

Zero Dropouts. 100% success. Here's How: ProRelix Research’s Approach to Reinventing Pinguecula & Pterygium Treatment with a Novel Eye Drop Therapy!

ProRelix Research was approached by a biotech company to manage a critical Phase I/II clinical trial involving an innovative eye drop formulation targeting

From Pandemic Pressure to Promising Potential: How We Fast-Tracked a COVID-19 Clinical Trial on an Emerging Investigational Antiviral Therapy

A Global Crisis Calls for Immediate Action: The outbreak of COVID-19 in late 2019 turned the world upside down, resulting in significant loss of life, overwhelming healthcare systems, and

the trial that will redefine gi motility disorder treatment prorelix research’s unprecedented findings on safety and efficacy of a traditional polyherbal formulation

The Trial That Will Redefine GI Motility Disorder Treatment: ProRelix's Unprecedented Findings on Safety and Efficacy of a Traditional Polyherbal Formulation

In the realm of gastrointestinal health, motility disorders continue to challenge both patients and physicians alike. Symptoms such as bloating, indigestion, abdominal discomfort, and irregular bowel habits often go undiagnosed or are

2 Pills That Could Save Lives? Inside the COVID Trial That Changed Everything

In the turbulent wake of the COVID-19 pandemic, when hospitals overflowed and oxygen cylinders became as precious as gold, the global medical community was united by one pressing question: How do we reduce mortality in moderate COVID-19 cases before they deteriorate into critical, ICU-level emergencies?

We Ran a 90-Day Clinical Trial on a Longevity Compound—Here’s What Changed in Just 3 Months

In an era where the lines between biotechnology and longevity science blur more each day, one compound has captured the attention of both researchers and the health-conscious public alike. Known for its potential to boost cellular energy levels and combat biological ageing, it has rapidly emerged

Email Us

info@prorelixresearch.com

Our Story

For Regulatory Submission

For Claims Support

Therapeutic Expertize

How we helped a biotech innovator overcome clinical trial obstacles: A journey to success!

Challenges

Challenge 1

Challenge 2

Challenge 3

Challenge 4

Solution: Patient Recruitment: 50% Faster Enrollment

Outcomes:

Solution: Regulatory Approval: 35% Faster Multi-Country Approvals

Outcomes:

Solution: Site Management: 60% Reduction in Compliance Issues

Outcomes:

The Final Results: A Trial Turned Around

A Step Closer to Saving Lives

View More Case Studies

How we helped a biotech innovator overcome clinical trial obstacles: A journey to success

Zero Dropouts. 100% success. Here's How: ProRelix Research’s Approach to Reinventing Pinguecula & Pterygium Treatment with a Novel Eye Drop Therapy!

From Pandemic Pressure to Promising Potential: How We Fast-Tracked a COVID-19 Clinical Trial on an Emerging Investigational Antiviral Therapy

The Trial That Will Redefine GI Motility Disorder Treatment: ProRelix's Unprecedented Findings on Safety and Efficacy of a Traditional Polyherbal Formulation

2 Pills That Could Save Lives? Inside the COVID Trial That Changed Everything

We Ran a 90-Day Clinical Trial on a Longevity Compound—Here’s What Changed in Just 3 Months

Subscribe to our Newsletter

Useful Links

Services

Sponsor

©2025, ProRelix Research LLC. All Rights Reserved.

Email Us

info@prorelixresearch.com

Our Story

Expert Clinical Research Services:

Portfolio

For Regulatory Submission

For Claims Support

Therapeutic Expertize

How we helped a biotech innovator overcome clinical trial obstacles: A journey to success!

Challenges

Challenge 1

Challenge 2

Challenge 3

Challenge 4

Solution: Patient Recruitment: 50% Faster Enrollment

Outcomes:

Solution: Regulatory Approval: 35% Faster Multi-Country Approvals

Outcomes:

Solution: Site Management: 60% Reduction in Compliance Issues

Outcomes:

The Final Results: A Trial Turned Around

A Step Closer to Saving Lives

View More Case Studies

How we helped a biotech innovator overcome clinical trial obstacles: A journey to success

Zero Dropouts. 100% success. Here's How: ProRelix Research’s Approach to Reinventing Pinguecula & Pterygium Treatment with a Novel Eye Drop Therapy!

From Pandemic Pressure to Promising Potential: How We Fast-Tracked a COVID-19 Clinical Trial on an Emerging Investigational Antiviral Therapy

The Trial That Will Redefine GI Motility Disorder Treatment: ProRelix's Unprecedented Findings on Safety and Efficacy of a Traditional Polyherbal Formulation

2 Pills That Could Save Lives? Inside the COVID Trial That Changed Everything

We Ran a 90-Day Clinical Trial on a Longevity Compound—Here’s What Changed in Just 3 Months

Subscribe to our Newsletter

Useful Links

Services

Sponsor

©2025, ProRelix Research LLC. All Rights Reserved.